English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Press Releases for Tuesday, October 6, 2020
NEC and NEC X Announce First Graduate from Corporate Accelerator Program 
18:06 HKT/SGT
6th Annual POWER WEEK ASIA Is Going Digital 
16:55 HKT/SGT
Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers 
16:08 HKT/SGT
Transgene社・NEC・BostonGene社、治験中の卵巣がんおよび頭頸部がん患者さんの遺伝子解析で協業 
16:00 HKT/SGT
eCommerce Expo Asia to announce Premium Retail Executive Summit in March 2021 
14:02 HKT/SGT
エーザイ、TLR4拮抗剤エリトランおよび抗FKN 抗体E6011を用いたCOVID-19治療薬の開発を目指す産学官共同研究開発契約を締結し、非臨床研究活動を開始 
14:00 HKT/SGT
JR East, Hitachi and Toyota to Develop Hybrid (Fuel Cell) Railway Vehicles Powered by Hydrogen 
13:29 HKT/SGT
Moonstake 스테이킹 총액이 본격적인 서비스 개시로부터 2개월만에 5천만달러 돌파 
12:00 HKT/SGT
Moonstakeのステーキング総額が53億円を突破―本格的なサービス開始から2ヶ月で達成 
12:00 HKT/SGT
Moonstake's total staking asset hits $50Million - Successfully achieved in two months from the start of full-scale service 
12:00 HKT/SGT
Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded 
11:07 HKT/SGT
Tianda Pharmaceuticals acquired and established a long-term relationship of Cooperation with Yeung & Young Medicare and Qi's Living 
11:00 HKT/SGT
Fujitsu Develops Digital Trust Management Technology to Ensure Authenticity of Business Data 
10:30 HKT/SGT
富士通、「CEATEC 2020 ONLINE」に出展 
10:00 HKT/SGT
富士通研究所、ビジネスデータの真正性を保証するデジタルトラスト仲介技術を開発 
10:00 HKT/SGT
トヨタと日野、北米で燃料電池大型トラックを共同で開発 
07:30 HKT/SGT
Kore.ai、アジア太平洋地域における会話型AIの大きな成長を期待、日本にオフィスを開設 
07:30 HKT/SGT
Toyota and Hino to Jointly Develop Class 8 Fuel Cell Electric Truck for North America 
05:43 HKT/SGT
 ACN Search:
 
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
 
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575